Introduction: Management of recurrent differentiated thyroid cancer (DTC) may include
surgery, radioactive iodine (RAI), and external beam radiotherapy (EBRT). Systemic therapy …

In the last decades, a surprising increased incidence of differentiated thyroid cancer (DTC),
along with a precocious diagnosis of “small” tumors and microcarcinomas have been …

Background: Persistent/recurrent disease in the neck is frequent in patients with
differentiated thyroid cancer (DTC). Objective: Assess efficacy, safety, and prognostic factors …

Background: Trends in the epidemiological profiles of differentiated thyroid cancer (DTC)
have shifted the disease spectrum. This study aimed to evaluate the recurrence rates and …

Opinion statement Papillary thyroid cancer (PTC), the most common thyroid malignancy, is
associated with cervical lymph node metastases in 30% to 90% of patients. While surgery is …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Abstract Background Several Japanese studies have focused on identifying prognostic
factors in patients with positive lymph nodes to predict recurrence rate and disease‐free …

Background and Objectives To present treatment outcomes and prognostic factors for
surgical management of locally advanced differentiated thyroid cancer (DTC). Methods …

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate …

Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …